Advances in Ophthalmology Series

image of past lectureDinner Lecture Series
Presented by UTHealth Houston Ophthalmology

Next meeting: February 6, 2025

Hotel ZaZa
5701 Main Street
Houston, Texas

Register here »

The Advances in Ophthalmology Dinner Lecture Series consists of multidisciplinary meetings hosted by UTHealth Houston Ophthalmology. These dinners gather local experts in ophthalmology and optometry, for presentations from subject matter experts, followed by discussion.

Each meeting will feature lectures from two to three physicians, and will be formatted to allow sufficient time for a question-and-answer period in order to provide an opportunity to explore the presented subject matter thoroughly. We expect the meetings to be highly interactive and full of scientific and clinical advances presented by local thought leaders in this discipline.

WINTER 2025 PROGRAM

5:30 pm – Reception | 6 pm – Dinner

Lectures & Discussion:

  • Assessment of and Advances in Surgical Management of Graves’ Disease – Timothy McCulley, MD
  • Graves’ Disease—Current Systemic Therapies and New Biologics to Consider – Ying Chen, MD

YING CHEN, MD
Assistant Professor
Director, Oculoplastic Surgery
Ruiz Department of Ophthalmology and Visual Science
McGovern Medical School at UTHealth Houston

TIMOTHY J. MCCULLEY, MD
Professor and Chair
Richard S. Ruiz, MD, Distinguished University Chair
Ruiz Department of Ophthalmology and Visual Science
McGovern Medical School at UTHealth Houston
Professor and Chair
Richard S. Ruiz, MD, Distinguished University Chair
Ruiz Department of Ophthalmology and Visual Science
McGovern Medical School at UTHealth Houston

Target Audience

This activity is designed to meet the educational needs of clinicians including endocrinologists, optometrists, and ophthalmologists.

  1. Recognize early signs of Graves’ ophthalmopathy and different types of systemic therapies.
  2. Review the recent advances and future therapies in management of Graves’ ophthalmopathy.
  3. Identify conservative measures to manage symptoms related to Graves’ ophthalmopathy.
  4. Review latest advances in surgical management of Graves’ ophthalmopathy.

Accreditation Statement/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Antidote Education Company and UTHealth Houston. Antidote is accredited by the ACCME to provide continuing medical education for physicians.

Antidote designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.